VANGUARD GROUP INC - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 40 filers reported holding REGULUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,096,000
+14.8%
3,678,334
+21.4%
0.00%
Q4 2021$955,000
-55.5%
3,030,213
-2.4%
0.00%
Q3 2021$2,145,000
-14.8%
3,105,045
+0.3%
0.00%
Q2 2021$2,517,000
-49.9%
3,095,237
-3.9%
0.00%
Q1 2021$5,025,000
+862.6%
3,220,758
+733.0%
0.00%
Q4 2020$522,000
+866.7%
386,659
+266.7%
0.00%
Q3 2020$54,000
+145.5%
105,449
+224.4%
0.00%
Q2 2020$22,000
+46.7%
32,5030.0%0.00%
Q1 2020$15,000
-48.3%
32,5030.0%0.00%
Q4 2019$29,000
+26.1%
32,5030.0%0.00%
Q3 2019$23,000
-43.9%
32,5030.0%0.00%
Q2 2019$41,000
-6.8%
32,503
-25.4%
0.00%
Q1 2019$44,000
-79.0%
43,573
-80.6%
0.00%
Q4 2018$210,000225,1780.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CVI Holdings, LLC 385,973$344,0000.48%
BVF INC/IL 2,035,695$1,812,0000.14%
Sarissa Capital Management LP 1,851,851$1,648,0000.14%
NEA Management Company, LLC 2,052,455$1,827,0000.09%
WEDBUSH SECURITIES INC 20,864$19,0000.00%
West Oak Capital, LLC 1,000$1,0000.00%
Rockefeller Capital Management L.P. 109,839$98,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 128,694$114,0000.00%
MORGAN STANLEY 100$00.00%
BLAIR WILLIAM & CO/IL 10,200$9,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders